Recently, increasing evidence indicates that TRMT6 is preferentially expressed in cancerous tissues and plays an oncogenic role in various types of cancer, such as glioma,3 bladder cancer1 and hepatocellular carcinoma (HCC).4, 5. Here, TRMT6 is linked to glioma.